Clinical trialNCT03278028CompletedPhase 2Interventional

A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts

SponsorAclaris Therapeutics, Inc.Enrollment159Common Wart

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The primary objective of this study is to evaluate the effectiveness of A-101 compared to Vehicle when applied to 1 Target common wart on the trunk or extremities twice a week.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Stuart D Shanler, MD
Aclaris Therapeutics
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Aclaris Investigational Site
Glendale, Arizona, United States
Aclaris Investigational Site
Fort Smith, Arkansas, United States
Aclaris Investigational Site
Encinitas, California, United States
Aclaris Investigational Site
Los Angeles, California, United States
Aclaris Investigational Site
Denver, Colorado, United States
Aclaris Investigational Site
Omaha, Nebraska, United States
Aclaris Investigational Site
Albuquerque, New Mexico, United States
Aclaris Investigational Site
Rochester, New York, United States
Aclaris Investigational Site
High Point, South Carolina, United States
Aclaris Investigational Site
Knoxville, Tennessee, United States
Aclaris Investigational Site
Nashville, Tennessee, United States
Aclaris Investigational Site
College Station, Texas, United States
Aclaris Investigational Site
Houston, Texas, United States
Aclaris Investigational Site
Salt Lake City, Utah, United States
Aclaris Investigational Site
Lynchburg, Virginia, United States
Aclaris Investigational Site
Norfolk, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

A-101 Topical SolutionA-101 Vehicle Solution

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 13 Jul 2017
Primary completion: 1 Mar 2018
Completion: 1 Mar 2018
Last update posted: 9 Apr 2019
Registered enrollment: 159
Registry id: NCT03278028

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.